Free Weight-Loss Drugs for Patients with Obesity, Diabetes in €5m Scheme

A new €5 million health scheme will provide free weight-loss drugs to patients diagnosed with obesity and diabetes, aiming to reduce long-term health complications and ease pressure on national healthcare services. The initiative targets individuals who meet clinical criteria for obesity or type 2 diabetes and have not responded to lifestyle interventions alone, with the medications prescribed under specialist supervision to ensure safety and effectiveness. Health authorities designed the program to address rising rates of obesity-related illness, noting that sustained weight reduction can improve blood sugar control, lower cardiovascular risk, and decrease reliance on hospital care. The scheme will cover approved weight-loss drugs through public health clinics and hospitals, with general practitioners and endocrinologists involved in patient assessment, monitoring, and follow-up to track outcomes. Officials say the investment reflects a shift toward preventive care, projecting that better management of weight and diabetes at an earlier stage will deliver both clinical benefits for patients and cost savings for the health system over time.